Standard-of-Care HRRm Testing Underutilized in Patients With mCRPC
January 25th 2024Despite germline and somatic testing being the standard of care for patients with metastatic castration-resistant prostate cancer, rates of its real-world use shows that it may be underutilized, which may negatively impact therapeutic offerings.
COVID-19 Pandemic Emphasizes Disparities in Cancer Care
September 17th 2021“We’ve had periods of time where things were shut down. We do have telemedicine, that was expanded, but telemedicine doesn’t work for everyone. If you don’t have internet access, if you don’t have the ability to understand the technology….”
COVID-19 Vaccine Benefits Outweigh Risk, Despite Cardiac Concerns, Expert Says
June 18th 2021Many patients with cancer may feel uneasy about the COVID-19 vaccines, especially as new stories break about potential heart complications. However, most patients should get the shot as soon as possible, says Brahm Segal, MD.